Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07640243Recruiting
Randomised trial of remifentanil and ketamine in biliary obstruction (2 arms), sponsored by Ankara City Hospital. Primary endpoint: Recovery Time up to 30 minutes. Started Feb 2026; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07640243.